Healthcare
EGIS Pharmaceuticals Plc - Strategic Analysis Review
| Publication Date | March 2009 |
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 11 |
| ISBN Number | not applicable |
| Product Code | GMD01903 |
Price
approximately: $125 | €91
Order above formats by FAX
Summary
EGIS Pharmaceuticals Plc - Strategic Analysis Review
EGIS Pharmaceuticals Plc (EGIS) is a pharmaceutical company focused on research, development and sale of pharmaceuticals and active pharmaceutical ingredients (API). The company has principal operations in Europe. EGIS operates in three main focused areas namely; production of pharmaceuticals and API; pharmaceutical research and development; and sale of final products and API.
Global Markets Direct, the leading business information provider, presents an in-depth strategic and operational analysis of EGIS Pharmaceuticals Plc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.
Scope
- The company's strengths and weaknesses and areas of development or decline are analyzed. Strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information - business structure and operations, company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers' businesses better.
- Get detailed information and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers - with key data on their businesses and locations.
- Capitalize on competitors' weaknesses and target the market opportunities available to them.
- Scout for potential acquisition targets, with detailed insight into the companies' strategic and operational performance.
Contents
- Key Information
- Key Facts
- List of Tables
- Company Overview
- Major Products and Services
- Overview
- History
- SWOT Analysis Overview
- Overview
- EGIS Pharmaceuticals Plc - Strengths
- Strong Revenue Growth
- Focused R&D
- Diversified Geographic Presence
- EGIS Pharmaceuticals Plc - Weaknesses
- Local Markets
- EGIS Pharmaceuticals Plc - Opportunities
- Focus on Commonwealth of Independent States
- Increasing Generics
- Products for Domestic Markets
- Emerging Markets
- EGIS Pharmaceuticals Plc - Threats
- Introduction of REACH
- Domestic Government Regulations
- Competitive Pressure
- Increased Scrutiny on Drug Imports
- Key Competitors
- Key Employees
- Key Employee Biographies
- Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Appendix
- Methodology
- About Global Markets Direct
- Contact Us
- Disclaimer
- List of Tables
- EGIS Pharmaceuticals Plc, Key Facts
- EGIS Pharmaceuticals Plc, Key Employees
- EGIS Pharmaceuticals Plc, Key Facts
- Major Products and Services
- EGIS Pharmaceuticals Plc, History
- EGIS Pharmaceuticals Plc, Key Employees
- EGIS Pharmaceuticals Plc, Key Employee Biographies
- EGIS Pharmaceuticals Plc, Other Locations
